Thomas Carlton Hofstra

Thomas Carlton Hofstra, MD is a Clinical Assistant Professor of Pediatrics at the University of Southern California, affiliated with Children's Hospital Los Angeles (CHLA) and the CHLA Medical Group. His research focuses on pediatric hematology with an emphasis on iron overload management in transfusion-dependent conditions such as sickle cell disease and thalassemia. Key areas include understanding iron deposition in vital organs, developing diagnostic tools for microcytic anemias, and evaluating therapeutic interventions like luspatercept.

Dr. Hofstra's work bridges clinical practice and scientific inquiry, addressing challenges in hemoglobinopathies, autoimmune hemolytic anemias, and immunodeficiency-related complications. He has contributed to studies on combined iron chelation therapies, nutritional deficiencies in iron-overloaded patients, and novel approaches to managing hemophagocytic lymphohistiocytosis. His publications span three decades, demonstrating sustained engagement with pediatric hematologic disorders.

His professional profile reflects a commitment to advancing care through translational research and evidence-based treatments. Collaborations include clinical trials and case studies that inform guidelines for rare pediatric conditions. Though no awards are explicitly listed, his prolific publication record underscores significant contributions to the field.